Literature DB >> 17524495

Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis.

D Neil Wedlock1, Michel Denis, H Martin Vordermeier, R Glyn Hewinson, Bryce M Buddle.   

Abstract

A number of studies have demonstrated significant protection of cattle against bovine tuberculosis following vaccination with the Pasteur strain of Mycobacterium bovis bacille Calmete-Guerin (BCG). However, it is unclear if other daughter strains of BCG are as effective, which is an important issue to resolve for a variety of regulatory compliance issues. This study compared the protective immune responses to bovine tuberculosis induced in cattle vaccinated with BCG Danish with those induced by BCG Pasteur. Groups of calves (n=10) were vaccinated with 10(6) colony forming units (CFU) BCG Pasteur prepared from a fresh liquid culture, 10(6) CFU BCG Danish prepared from a fresh liquid culture or 0.4 mg of reconstituted freeze-dried culture of BCG Danish. Another group (n=10) served as non-vaccinated controls. BCG Pasteur induced significantly higher and more sustained levels of bovine purified protein derivative (PPD)-specific gamma interferon (IFN-gamma) in whole-blood cultures following vaccination compared to either fresh culture BCG Danish or freeze-dried BCG Danish. Vaccination with a fresh culture of BCG Pasteur, fresh culture BCG Danish and freeze-dried BCG Danish gave a significant enhancement in three, four and three pathological and microbiological parameters of protection, respectively, compared to the non-vaccinated group. These results demonstrate the Danish strain of BCG is a viable alternative to BCG Pasteur for vaccination of cattle as both strains had similar efficacy and there was little difference between freshly cultured and freeze-dried formulation of BCG Danish. The results also show that post-vaccination antigen-specific IFN-gamma levels in whole blood is not always a reliable indicator of protection against a subsequent virulent challenge.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17524495     DOI: 10.1016/j.vetimm.2007.04.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  21 in total

1.  Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.

Authors:  J C Hope; M L Thom; M McAulay; E Mead; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Tuberculin Skin Testing Boosts Interferon Gamma Responses to DIVA Reagents in Mycobacterium bovis-Infected Cattle.

Authors:  Gareth J Jones; Mick Coad; Bhagwati Khatri; Javier Bezos; Natalie A Parlane; Bryce M Buddle; Bernardo Villarreal-Ramos; R Glyn Hewinson; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2017-05-05

3.  Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.

Authors:  M L Thom; M McAulay; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos; J C Hope
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

Review 4.  Tuberculosis vaccines and prevention of infection.

Authors:  Thomas R Hawn; Tracey A Day; Thomas J Scriba; Mark Hatherill; Willem A Hanekom; Thomas G Evans; Gavin J Churchyard; James G Kublin; Linda-Gail Bekker; Steven G Self
Journal:  Microbiol Mol Biol Rev       Date:  2014-12       Impact factor: 11.056

5.  Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.

Authors:  Bernat Pérez de Val; Bernardo Villarreal-Ramos; Miquel Nofrarías; Sergio López-Soria; Nadine Romera; Mahavir Singh; F Xavier Abad; Zhou Xing; H Martin Vordermeier; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

6.  Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis.

Authors:  Robert S Wallis; Solange Vinhas; Ernestas Janulionis
Journal:  Tuberculosis (Edinb)       Date:  2009-03-24       Impact factor: 3.131

7.  Subcutaneous administration of a 10-fold-lower dose of a commercial human tuberculosis vaccine, Mycobacterium bovis bacillus Calmette-Guerin Danish, induced levels of protection against bovine tuberculosis and responses in the tuberculin intradermal test similar to those induced by a standard cattle dose.

Authors:  Bryce M Buddle; R Glyn Hewinson; H Martin Vordermeier; D Neil Wedlock
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

8.  Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice.

Authors:  Bo Young Jeon; Steven C Derrick; Jaehyun Lim; Kristopher Kolibab; Veerabadran Dheenadhayalan; Amy Li Yang; Barry Kreiswirth; Sheldon L Morris
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

9.  Efficacy of a vaccine formula against tuberculosis in cattle.

Authors:  Germinal J Canto Alarcon; Yezenia Rubio Venegas; Luis Bojorquez Narvaez; Oscar E Pizano Martínez; Leticia García Casanova; Susana Sosa Gallegos; Alejandro Nava Vargas; Andrea M Olvera Ramírez; Feliciano Milian Suazo
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.

Authors:  Elma Z Tchilian; Christiane Desel; Emily K Forbes; Silke Bandermann; Clare R Sander; Adrian V S Hill; Helen McShane; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.